As
Askbio (Bayer)
RTP NCFounded 2001200 employees
Private CapbiotechAcquiredGenetic Medicine
Platform: AAV Pro10
Market Cap
N/A
All Drugs
4
Clinical Trials
5
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ASK-1666 | ASK-1666 | Approved | 2 | CD38 | Melanoma | ||
| Polalemzoparlimab | ASK-1315 | Phase 2/3 | 1 | MDM2 | RA | ||
| Lirafotisoran | ASK-8387 | Preclinical | 1 | DLL3 | DLBCL | ||
| ASK-539 | ASK-539 | NDA/BLA | 1 | CGRP | MG |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)